Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Yarden

Showing results (81-90 of 166) with videos related to

Pageof 17
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1991
Mechanistic aspects of the opposing effects of monoclonal antibodies to the ERBB2 receptor on tumor growthI Stancovski, E Hurwitz, O Leitner, et al.
Oncogene|January 7, 1998
Differential expression of NDF/neuregulin receptors ErbB-3 and ErbB-4 and involvement in inhibition of neuronal differentiationR Pinkas-Kramarski, R Eilam, I Alroy, et al.
Oncogene|March 7, 2000
Molecular requirements for the effect of neuregulin on cell spreading, motility and colony organizationA Chausovsky, H Waterman, M Elbaum, et al.
The American Journal of Pathology|February 1, 1996
Type 1 receptor tyrosine kinases are differentially phosphorylated in mammary carcinoma and differentially associated with steroid receptorsS S Bacus, D Chin, Y Yarden, et al.
The EMBO Journal|May 1, 1992
A confined variable region confers ligand specificity on fibroblast growth factor receptors: implications for the origin of the immunoglobulin foldA Yayon, Y Zimmer, G H Shen, et al.
The EMBO Journal|March 1, 1993
Cell-type specific interaction of Neu differentiation factor (NDF/heregulin) with Neu/HER-2 suggests complex ligand-receptor relationshipsE Peles, R Ben-Levy, E Tzahar, et al.
The Journal of Biological Chemistry|March 28, 1998
Csk homologous kinase, a novel signaling molecule, directly associates with the activated ErbB-2 receptor in breast cancer cells and inhibits their proliferationS Zrihan-Licht, B Deng, Y Yarden, et al.
Immunology Letters|February 13, 2001
Specific inhibition of the reaction between a tumor-inhibitory antibody and the ErbB-2 receptor by a mimotope derived from a phage display libraryN Vaisman, A Nissim, L N Klapper, et al.
Genes, Chromosomes & Cancer|September 1, 1994
The Heregulin gene can be included in the 8p12 amplification unit in human breast cancerJ Adélaïde, F Penault-Llorca, A Dib, et al.
Oncogene|March 7, 1996
Coupling of the c-Cbl protooncogene product to ErbB-1/EGF-receptor but not to other ErbB proteinsG Levkowitz, L N Klapper, E Tzahar, et al.
Pageof 17

Showing results (81-90 of 166) with videos related to

Sort By:
Pageof 17
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1991
Mechanistic aspects of the opposing effects of monoclonal antibodies to the ERBB2 receptor on tumor growthI Stancovski, E Hurwitz, O Leitner, et al.
Oncogene|January 7, 1998
Differential expression of NDF/neuregulin receptors ErbB-3 and ErbB-4 and involvement in inhibition of neuronal differentiationR Pinkas-Kramarski, R Eilam, I Alroy, et al.
Oncogene|March 7, 2000
Molecular requirements for the effect of neuregulin on cell spreading, motility and colony organizationA Chausovsky, H Waterman, M Elbaum, et al.
The American Journal of Pathology|February 1, 1996
Type 1 receptor tyrosine kinases are differentially phosphorylated in mammary carcinoma and differentially associated with steroid receptorsS S Bacus, D Chin, Y Yarden, et al.
The EMBO Journal|May 1, 1992
A confined variable region confers ligand specificity on fibroblast growth factor receptors: implications for the origin of the immunoglobulin foldA Yayon, Y Zimmer, G H Shen, et al.
The EMBO Journal|March 1, 1993
Cell-type specific interaction of Neu differentiation factor (NDF/heregulin) with Neu/HER-2 suggests complex ligand-receptor relationshipsE Peles, R Ben-Levy, E Tzahar, et al.
The Journal of Biological Chemistry|March 28, 1998
Csk homologous kinase, a novel signaling molecule, directly associates with the activated ErbB-2 receptor in breast cancer cells and inhibits their proliferationS Zrihan-Licht, B Deng, Y Yarden, et al.
Immunology Letters|February 13, 2001
Specific inhibition of the reaction between a tumor-inhibitory antibody and the ErbB-2 receptor by a mimotope derived from a phage display libraryN Vaisman, A Nissim, L N Klapper, et al.
Genes, Chromosomes & Cancer|September 1, 1994
The Heregulin gene can be included in the 8p12 amplification unit in human breast cancerJ Adélaïde, F Penault-Llorca, A Dib, et al.
Oncogene|March 7, 1996
Coupling of the c-Cbl protooncogene product to ErbB-1/EGF-receptor but not to other ErbB proteinsG Levkowitz, L N Klapper, E Tzahar, et al.
Pageof 17